FDA Allows Consumer Genetic Cancer Testing

The FDA gave the go-ahead to 23andMe to offer over-the-counter cancer-screening for a few specific mutations, in what will surely raise questions about how predictions themselves can change lives and likely pressure people into genetic engineering.

Source